Parathyroid hormone and risk of heart failure in the general population: A meta-analysis of prospective studies

Medicine (United States)

Volumn 95, Issue 40, 2016, Pages

  Meng, Fanbo ^a   Wang, Wei ^a   Ma, Jianghong ^a   Lin, Baisong ^a  

^a CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Heart failure; Meta analysis; Parathyroid hormone

Indexed keywords

PARATHYROID HORMONE;

ADULT; ARTICLE; BIBLIOGRAPHIC DATABASE; CARDIOVASCULAR RISK; CLINICAL EVALUATION; CNKI DATABASE; DISEASE ASSOCIATION; EMBASE; HEART FAILURE; HIGH RISK POPULATION; HUMAN; MEDLINE; MIDDLE AGED; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SYSTEMATIC REVIEW; VIP DATABASE; WANFANG DATABASE; BLOOD; META ANALYSIS; RISK FACTOR;

HEART FAILURE; HUMANS; OBSERVATIONAL STUDIES AS TOPIC; PARATHYROID HORMONE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84995704529     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000004810     Document Type: Article

References (28)

1. Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004;292:344-50.
2. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 2015;131:e29-322.
3. Heidenreich PA, Albert NM, Allen LA, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail 2013;6:606-19.
4. Hu SS, Kong LZ, Gao RL, et al. Outline of the report on cardiovascular disease in China, 2010. Biomed Environ Sci 2012;25:251-6.
5. Tomaschitz A, Ritz E, Pieske B, et al. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease. Metabolism 2014;63:20-31.
6. Hagstrom E, Ingelsson E, Sundstrom J, et al. Plasma parathyroid hormone and risk of congestive heart failure in the community. Eur J Heart Fail 2010;12:1186-92.
7. Kestenbaum B, Katz R, de Boer I, et al. Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol 2011;58:1433-41.
8. Wannamethee SG, Welsh P, Papacosta O, et al. Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease. Circ Heart Fail 2014;7:732-9.
9. di Giuseppe R, Buijsse B, Hirche F, et al. Plasma fibroblast growth factor 23, parathyroid hormone, 25-hydroxyvitamin D3, and risk of heart failure: a prospective, case-cohort study. J Clin Endocrinol Metab 2014;99:947-55.
10. Bansal N, Zelnick L, Robinson-Cohen C, et al. Serum parathyroid hormone and 25-hydroxyvitamin D concentrations and risk of incident heart failure: the Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc 2014;3:e001278.
11. Folsom AR, Alonso A, Misialek JR, et al. Parathyroid hormone concentration and risk of cardiovascular diseases: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 2014;168:296-302.
12. Li Y, Chen C, Liu HL, et al. Vitamin D, parathyroid hormone, and heart failure in a chinese elderly population. Endocr Pract 2015;21:30-40.
13. Schierbeck LL, Jensen TS, Bang U, et al. Parathyroid hormone and vitamin D-markers for cardiovascular and all cause mortality in heart failure. Eur J Heart Fail 2011;13:626-32.
14. SugimotoT, TanigawaT, Onishi K, et al. Serumintactparathyroidhormone levels predict hospitalisation for heart failure. Heart 2009;95:395-8.
15. Wu GY, Zong GJ, Chen JK, et al. Serum parathyroid hormone levels predict hospitalization in outpatients of heart failure: a preliminary study. Zhonghua Yi Xue Za Zhi 2013;93:2205-8.
16. van Ballegooijen AJ, Reinders I, Visser M, et al. Parathyroid hormone and cardiovascular disease events: a systematic review and meta-analysis of prospective studies. Am Heart J 2013;165:655-64. 664 e651-655.
17. Yang B, Lu C, Wu Q, et al. Parathyroid hormone, cardiovascular and all-cause mortality: a meta-analysis. Clin Chim Acta 2016;455: 154-60.
18. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12.
19. Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp.
20. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.
21. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
22. Taylor AL. Heart failure in women. Curr Heart Fail Rep 2015;12: 187-95.
23. Gruson D, Buglioni A, Burnett JCJr. PTH: potential role in management of heart failure. Clin Chim Acta 2014;433:290-6.
24. Bosworth C, Sachs MC, Duprez D, et al. Parathyroid hormone and arterial dysfunction in the multi-ethnic study of atherosclerosis. Clin Endocrinol (Oxf) 2013;79:429-36.
25. Pirro M, Manfredelli MR, Helou RS, et al. Association of parathyroid hormone and 25-OH-vitamin D levels with arterial stiffness in postmenopausal women with vitamin D insufficiency. J Atheroscler Thromb 2012;19:924-31.
26. Taylor EN, Curhan GC, Forman JP. Parathyroid hormone and the risk of incident hypertension. J Hypertens 2008;26:1390-4.
27. van Ballegooijen AJ, Kestenbaum B, Sachs MC, et al. Association of 25-hydroxyvitamin D and parathyroid hormone with incident hypertension: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2014;63:1214-22.
28. Soares AA, Freitas WM, Japiassu AV, et al. Enhanced parathyroid hormone levels are associated with left ventricle hypertrophy in very elderly men and women. J Am Soc Hypertens 2015;9:697-704.